Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALNY · against 1,216 other Healthcare companies
Ranked #32 of 1,217 · scores higher than 97% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including ALNY · Click a bar to see the companies
Mainly thanks to its revenue growth, 3-year revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
| Metric | ALNY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 95.1% | 6.1% | 94% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 57.2% | 5.8% | 93% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 20 | 217M AUD (≈$143M) | 98 | 43 | |
| 20 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 9.3B USD |
| 98 |
| 64 |
| 32 | 2.6B CNY (≈$359M) | 97 | 52 |
| 32 | 14.87T KRW (≈$10.7B) | 97 | 76 |
| 32 | 21.4B USD | 97 | 67 |
| 32 | 4.0B USD | 97 | 56 |
| 32 | 110M USD | 97 | 38 |
| 32 | 7.3B USD | 97 | 74 |
| 32 | 4.4B AUD (≈$2.9B) | 97 | 51 |